Pfizer Limited (BOM:500680)
India · Delayed Price · Currency is INR 4,606.40
-122.50 (-2.59%)
At close: May 13, 2026
Pfizer Market Cap
Pfizer has a market cap or net worth of 211.06 billion as of May 14, 2026. Its market cap has increased by 8.72% in one year.
Market Cap
211.06B
Enterprise Value
180.65B
Revenue
24.82B
Ranking
n/a
PE Ratio
24.73
Stock Price
4,606.40
Market Cap Chart
Since March 12, 1999, Pfizer's market cap has increased from 33.02B to 211.06B, an increase of 539.26%. That is a compound annual growth rate of 7.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 211.06B | -7.50% |
| Dec 31, 2025 | 228.18B | -5.56% |
| Dec 31, 2024 | 241.62B | 23.72% |
| Dec 29, 2023 | 195.29B | -3.67% |
| Dec 30, 2022 | 202.74B | -12.34% |
| Dec 31, 2021 | 231.27B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 590.24B |
| GlaxoSmithKline Pharmaceuticals | 412.66B |
| J. B. Chemicals & Pharmaceuticals | 354.49B |
| AstraZeneca Pharma India | 213.47B |
| Jubilant Pharmova | 157.90B |
| Rubicon Research | 156.75B |
| Caplin Point Laboratories | 140.89B |
| CORONA Remedies | 107.38B |